A new trading day began on Monday, with MaxCyte Inc (NASDAQ: MXCT) stock price down -5.52% from the previous day of trading, before settling in for the closing price of $1.63. MXCT’s price has ranged from $1.26 to $5.20 over the past 52 weeks.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -11.37%. Meanwhile, its annual earnings per share averaged -9.62%. With a float of $98.09 million, this company’s outstanding shares have now reached $106.59 million.
MaxCyte Inc (MXCT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of MaxCyte Inc is 7.99%, while institutional ownership is 73.03%. The most recent insider transaction that took place on Jun 25 ’25, was worth 22,378. In this transaction Director of this company sold 10,684 shares at a rate of $2.09, taking the stock ownership to the 39,893 shares. Before that another transaction happened on Aug 13 ’25, when Company’s CHIEF FINANCIAL OFFICER bought 50,000 for $1.29, making the entire transaction worth $64,500. This insider now owns 161,811 shares in total.
MaxCyte Inc (MXCT) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.11 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -9.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.34% during the next five years compared to -11.37% drop over the previous five years of trading.
MaxCyte Inc (NASDAQ: MXCT) Trading Performance Indicators
Here are MaxCyte Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.42, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.40 in one year’s time.
Technical Analysis of MaxCyte Inc (MXCT)
Compared to the last year’s volume of 0.77 million, its volume of 0.49 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 31.76%.
During the past 100 days, MaxCyte Inc’s (MXCT) raw stochastic average was set at 24.56%, which indicates a significant increase from 7.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1150 in the past 14 days, which was higher than the 0.1077 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5326, while its 200-day Moving Average is $2.5372. Nevertheless, the first resistance level for the watch stands at $1.6267 in the near term. At $1.7133, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.7567. If the price goes on to break the first support level at $1.4967, it is likely to go to the next support level at $1.4533. Should the price break the second support level, the third support level stands at $1.3667.
MaxCyte Inc (NASDAQ: MXCT) Key Stats
With a market capitalization of 164.17 million, the company has a total of 106,607K Shares Outstanding. Currently, annual sales are 38,630 K while annual income is -41,060 K. The company’s previous quarter sales were 8,510 K while its latest quarter income was -12,360 K.
